The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of a proliferation-based mRNA signature to predict outcome in early-stage non-small cell lung adenocarcinoma.
Carmen Behrens
Research Funding - Myriad Genetics (I)
Francesca Lombardi
No relevant relationships to disclose
Susanne Wagner
Employment or Leadership Position - Myriad Genetics
Honoraria - Myriad Genetics
Junya Fujimoto
No relevant relationships to disclose
Maria G Raso
No relevant relationships to disclose
Lorenzo Spaggiari
No relevant relationships to disclose
Domenico Galetta
No relevant relationships to disclose
Elisha Huges
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics (I)
Julia E. Reid
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Zaina Sangale
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Stephen Swisher
No relevant relationships to disclose
Neda Kalhor
No relevant relationships to disclose
Cesar Moran
No relevant relationships to disclose
Alexander Gutin
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jerry S. Lanchbury
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Edward S. Kim
No relevant relationships to disclose
Massimo Barberis
No relevant relationships to disclose
Ignacio I. Wistuba
Research Funding - Myriad Genetics